M.D. Sass Enters ETF Arena With High-Conviction Value Strategy

by George Flores

NEW YORK, NY – March 04, 2026 – M.D. Sass, an asset management firm with a five-decade history of serving institutional clients, has made its long-awaited debut in the exchange-traded fund market. The firm today launched the M.D. Sass Concentrated Value ETF (Ticker: SASS) on the New York Stock Exchange, making its flagship value strategy accessible to the broader public for the first time.

The new actively managed fund begins trading with significant momentum, backed by over $70 million in seed capital from the firm’s existing clients and principals. The launch marks a pivotal strategic shift for the venerable firm, embracing the liquid and transparent ETF structure to deliver a high-conviction investment approach to a new generation of investors.

A Legacy of Value Meets a Modern Vehicle

For over 50 years, M.D. Sass has built a reputation for its rigorous, research-driven investment strategies, traditionally reserved for a clientele of public funds, corporations, and endowments. The firm's decision to enter the bustling ETF marketplace represents a significant evolution, bridging its long-standing heritage with the demands of modern finance.

"An ETF launch continues the firm's history of delivering innovative solutions for our clients for over 50 years," said Martin D. Sass, the firm's Founder and CEO. He emphasized that the move was a natural progression, stating, "The liquid, transparent, and tax-efficient structure of an actively managed ETF enables us to bring our deeply researched and highest-conviction views to the investment marketplace at large."

This democratization of an institutional-grade strategy is a growing trend in asset management. By packaging its Concentrated Value strategy into an ETF, M.D. Sass is not only expanding its potential investor base but also responding to a clear market demand for active management within the accessible and efficient ETF wrapper. The firm is leveraging its deep history of identifying what it calls "undiscovered and misperceived opportunities" and offering that expertise to all investors, from sophisticated retail traders to financial advisors building client portfolios.

A Contrarian Play in an AI-Dominated Market

The timing of the SASS ETF launch is a strategic move in itself. The firm is explicitly positioning the fund as an antidote to the extreme market concentration that has defined recent years. U.S. equity markets have become increasingly top-heavy, dominated by a handful of mega-cap technology and AI-infrastructure stocks.

By mid-2025, the top ten companies accounted for nearly 40% of the S&P 500's market capitalization, a level of concentration exceeding even the peak of the dot-com bubble. This has led to what some analysts call an "illusion of safety," where investors in broad market indexes are unknowingly making a concentrated bet on a single sector. Ari Sass, President of M.D. Sass and the portfolio manager for the new ETF, sees this as a critical moment for active value investors.

"We believe the launch of SASS is especially timely today given the U.S. equity market's heavy concentration in AI-infrastructure stocks, which provides insufficient diversification and risk management," Ari Sass stated. The fund’s strategy offers a deliberate alternative, seeking value in areas of the market that may be overlooked amid the frenzy for AI-related names.

This contrarian stance is the core of the ETF's value proposition. While the so-called "Magnificent 7" have driven the majority of market returns, M.D. Sass is betting that a disciplined, research-intensive approach can uncover compelling opportunities in less crowded spaces, providing investors with a much-needed source of diversification.

Inside the High-Conviction Strategy

The M.D. Sass Concentrated Value ETF is not a sprawling, index-hugging fund. It is the direct reflection of a disciplined and focused institutional strategy that Ari Sass has managed since 2019—a strategy that has consistently ranked in the top decile of its category and had grown to over $2 billion in assets by mid-2025.

"Concentrated Value is a high conviction, opportunistic U.S. equity strategy focused on a differentiated portfolio of 20-25 large and mid-cap stocks," Ari Sass explained. This concentrated nature means each holding is a significant, deeply researched bet. "We seek investment opportunities where our outlook for earnings is materially above consensus and where we believe valuation provides a compelling risk/reward."

The investment philosophy is centered on finding companies undergoing positive fundamental change or benefiting from secular trends that the broader market has yet to fully appreciate. This earnings-centric approach is complemented by what the firm describes as a culture of "intellectual honesty, transparency and communication," which enables it to "act decisively when new information may invalidate prior beliefs."

Unlike many value funds, SASS will not pay a dividend, focusing exclusively on long-term capital appreciation. With an expense ratio of 0.75%, it is priced competitively within the active ETF space, where the average fee is 0.73%. The fund enters a dynamic and growing market, competing with established active value ETFs but aiming to differentiate itself through its highly concentrated portfolio and the proven track record of its underlying strategy.

As with any investment, potential investors should consider the inherent risks. The fund's prospectus notes that as a non-diversified ETF, gains or losses in a single stock can have a greater impact on performance. Furthermore, its value-oriented approach may cause it to perform differently from the market as a whole and potentially underperform growth-focused strategies during certain periods. As a new fund, it has no operating history as an ETF, and its ability to attract and maintain a viable asset level will be a key factor in its long-term success. However, for investors seeking a truly active and differentiated approach to value investing, the launch of SASS offers a compelling new option.